Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
7 Out Of 10 Gen Z Will Keep Being Vegan In The Next 5 Years - Gen Z Is Leading The Veganism Trend, Data Says 2023-03-30 23:48
Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators 2023-03-30 22:52
HistoSonics Announces First Ever Kidney Tumor Treatment Using Histotripsy 2023-03-30 22:12
DISCOVERY LIFE SCIENCES INSTALLS WORLD'S LARGEST COMMERCIAL FLEET OF NOVASEQ X PLUS SYSTEMS TO ACCELERATE GENOMIC RESEARCH WITH UNPRECEDENTED SPEED AND COST EFFICIENCY 2023-03-30 21:05
IMG Travel Outlook Survey Predicts Continued Surge of International Travel in 2023 2023-03-30 21:00
Actinogen presents positive Phase 2a Xanamem data in at ADPD™ Alzheimer's and Parkinson's diseases conference 2023-03-30 21:00
ACROBiosystems' new strategic focus - streamlining the transition from preclinical development to commercialization 2023-03-30 20:51
Turn Biotechnologies Introduces its Dermatology Platform to the European Aesthetic Community at AMWC 2023-03-30 20:00
Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform 2023-03-30 20:00
ACROBiosystems' new strategic focus - streamlining the transition from preclinical development to commercialization 2023-03-30 18:54
DxVx Co., Ltd.'s affiliated company, Oxford Vacmedix (OVM) successfully completed Phase 1a in clinical trial of novel cancer vaccine OVM-200 2023-03-30 17:39
Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million 2023-03-30 15:49
Great Place To Work unveils Best Workplaces in the Inaugural Singapore Healthcare and Biopharma List 2023 2023-03-30 12:00
USANA Ranked #1 Direct Selling Brand for Calcium Supplements in Hong Kong 2023-03-30 10:49
Zimmer Biomet's ROSA HIP with ONE Planner Hip Awarded Orthopaedic Product Innovation of the Year by Healthcare Asia Medtech Awards 2023 2023-03-30 08:00
JW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 406 Patients 2023-03-30 08:00
ImmVira's oncolytic product MVR-C5252 targeting malignant glioma obtained NMPA's approval for Clinical Trial in China 2023-03-30 08:00
Athos Therapeutics Receives Regulatory Approval to Commence Phase I Clinical Trial of ATH-063 2023-03-30 03:32
Broncus Medical (02216.HK) Announces Annual Results for 2022 2023-03-30 01:05
PM Lee receives a first-hand update by Biosyngen on its progress in cell therapy 2023-03-29 22:53
1 249 250 251 252 253 1594